Abstract:Mingfei Guo, 1, 2 Jiarong Gao, 3 Lei Jiang, 4 Yaji Dai 4 1 Department of Scientific Research, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China; 2 Anhui Public Health Clinical Center, Hefei, Anhui, People's Republic of China; 3 Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, People's Republic of China; 4 Department of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, Anhui, People's Republic of China Correspondence: Yaji Dai, Department of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, Anhui, People's Republic of China, Email Background: Diabetic nephropathy (DN), as a chronic inflammatory complication of diabetes, is characterized by hyperglycemia, albuminuria and edema, which ultimately becomes the leading cause of end-stage renal disease (ESRD). Astragalus polysaccharide (APS), extracted from the Astragalus membranaceus , was widely used in the treatment of diabetes mellitus. However, the functional roles of APS ameliorate inflammatory responses in DN, which remain poorly understood. Therefore, the purpose of this study was to explore the molecular mechanism of APS on DN in vivo and vitro models. Methods: We explored the beneficial effects of APS in streptozotocin (STZ)-induced DN rat model and high glucose (HG)-treated glomerular podocyte model. The fasting blood glucose (FBG) and ratio of kidney weight to body weight were measured after 4 weeks of APS treatment. The renal injury parameters containing serum creatinine (Scr), blood urea nitrogen (BUN) and 24 h urinary protein were evaluated. The renal pathological examination was observed by hematoxylin-eosin (HE) staining. The levels of IL-1β, IL-6 and MCP-1 were evaluated by ELISA assay. The proliferation of podocytes was determined using CCK-8 assay and flow cytometry. qRT-PCR and Western blot analysis were performed to determine the amounts of TLR4/NF-κB-related gene expression. Results: Our results indicated that APS effectively decreased the levels of FBG, BUN, Scr and renal pathological damage when compared with STZ-induced DN model group. Additionally, APS significantly ameliorated renal injury by reducing inflammatory cytokines IL-1β, IL-6, MCP-1 expression and inhibiting the TLR4/NF-κB pathway activity in DN rats. Consistent with the results in vitro, the HG-induced inflammatory response and proliferation of glomerular podocytes were also alleviated through APS administration. Conclusion: We found that APS ameliorated DN renal injury, and the mechanisms perhaps related to relieving inflammatory responses and attenuating the TLR4/NF-κB signaling pathway. Keywords: diabetic nephropathy, Astragalus polysaccharide, podocytes, TLR4/NF-κB, inflammatory response Diabetes nephropathy (DN) is one of the most important microvascular complications of diabetes patients, with hyperglycemia, proteinuria and decreased glomerular filtration rate in early stage. 1,2 In the wake of DN constantly aggravated, the pathological are mainly characterized by accumulation of extracellular matrix, decreased glomerular podocyte, thickened glomerular basement membranes and mesangial hypertrophy, which eventually leads to glomerulosclerosis and renal failure. 3–5 Accumulating evidence has demonstrated that its primary initiating mechanism is related to glucose and lipid metabolism disorder, and hemodynamic changes. 6,7 However, its development progression are caused by a variety of pathological mechanisms, containing cytokines, inflammatory responses, oxidative stress, fibrosis, etc. 8,9 Owing to the pathogenesis of DN is complex and has not been adequately elucidated, which potential mechanism of action is still being explored. 10,11 In addition, the current clinical treatments of DN are not absolutely effective and additional in-depth research is still needed. In general, DN has been considered endocrine and metabolic diseases, and an increasing research has emphasized that inflammatory responses play an important role in the progression of this pathology. 12,13 Hyperglycemia aggravates inflammation and stimulates the activation and release of various cytokines, chemokines, growth factors and cell adhesion molecules. Recent evidence has indicated that some inflammatory cytokines such as IL-1β, IL-6, MCP-1, TNF-α, and TGF-β1 played a critical role in hyperglycaemia-induced renal injury. 14,15 Therefore, inhibiting inflammatory responses and reducing the expression of cytokines will effectively improve renal injury and enhance renal function in DN. Previous researches have demonstrated that TLR4 -Abstract Truncated-

Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway

Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus

Effect of Astragaloside IV on Hepatic Glucose‐regulating Enzymes in Diabetic Mice Induced by a High‐fat Diet and Streptozotocin

Astragalus polysaccharide promotes autophagy and alleviates diabetic nephropathy by targeting the lncRNA Gm41268/PRLR pathway

Astragaloside I from Astragalus Attenuates Diabetic Kidney Disease by Regulating HDAC3/Klotho/TGF- β 1 Loop

Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease

Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling

Astragalus Polysaccharide Reduces Blood Pressure, Renal Damage, and Dysfunction Through the TGF-β1-ILK Pathway.

Astragalus polysaccharide attenuates diabetic nephropathy by reducing apoptosis and enhancing autophagy through activation of Sirt1/FoxO1 pathway

Polydatin Exhibits the Hepatoprotective Effects Through PPAR-α/-β Signaling Pathway in Streptozocin-induced Diabetic Mice

Astragaloside I from Astragalus Attenuates Diabetic Kidney Disease by Regulating HDAC3/Klotho/TGF-β1 Loop

Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway

Plantaginis semen ameliorates diabetic kidney disease via targeting the sphingosine kinase 1/sphingosine-1-phosphate pathway

Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice

Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy.

Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats

Effects of APS Activates Hepatic Insulin Signaling in HFD-induced IR Mice.

Regulatory effects of hawthorn polyphenols on hyperglycemic, inflammatory, insulin resistance responses, and alleviation of aortic injury in type 2 diabetic rats

Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation

Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in db/db Mice

Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat